GGrantIndex
Sort

130,381 grants matching hiv

The Ohio State University AIDS Clinical Trials Unit

$2,542,078
Susan L Koletar · Ohio State University · U01 · FY2008 · AI

NONHUMAN PRIMATE CORE CELLULAR IMMUNOLOGY LABORATORY FOR AIDS

$2,540,338
Norman L Letvin · Beth Israel Deaconess Medical Center · N01 · FY2011 · AI

University of North Carolina Global HIV Prevention and Treatment Clinical Trials

$2,540,071
Joseph J. Eron · Univ Of North Carolina Chapel Hill · UM1 · FY2016 · AI

The Biology of HIV Transmission

$2,539,801
Frederick M Hecht · University Of California, San Francisco · P01 · FY2007 · AI

Psychotherapy Development Research Center

$2,537,791
Kathleen M Carroll · Yale University · P50 · FY2017 · DA

IMPAACT Leadership Group

$2,537,610
Sharon A Nachman · Johns Hopkins University · UM1 · FY2025 · AI

DESIGN, IMPLEMENT & MAINTAIN ROUTINE CASE, INCIDENCE DATA LINKAGE OF HIV INFECTIO

$2,537,243
Rebecca T. Filipowicz · Texas State Dept Of Health Services · U62 · FY2014 · PS

National HIV Surveillance System (NHSS)

$2,537,243
Rebecca T. Filipowicz · Texas State Dept Of Health Services · U62 · FY2015 · PS

Psychotherapy Development Research Center

$2,535,538
Kathleen M Carroll · Yale University · P50 · FY2015 · DA

Clinical Epidemiology and Pathogenesis of Asymptomatic HSV

$2,535,398
Anna Wald · University Of Washington · P01 · FY2017 · AI

MACS/WIHS Combined Cohort Study: Cook County Clinical Research Site (CC_CRS)

$2,535,000
Audrey French · Hektoen Institute For Medical Research · U01 · FY2019 · HL

NIDA Clinical Trials Network: Greater New York Node

$2,533,075
John P Rotrosen · New York University School Of Medicine · UG1 · FY2019 · DA

Maternal and infant immunization to eliminate breast milk transmission of HIV-1

$2,532,602
Sallie R. Permar · Duke University · P01 · FY2016 · AI

Epitope-targeted Vaccines for HIV-1 Prevention

$2,532,157
Xiangpeng Kong · New York University School Of Medicine · P01 · FY2013 · AI

International Epidemiologic Databases to Evaluate AIDS - Southern Africa (IeDEA-SA)

$2,531,588
Matthias Egger · Universitat Bern · U01 · FY2018 · AI

Elucidating single cell changes in neurogenic brain regions during HIV and cannabinoid exposure

$2,531,125
Lishomwa C Ndhlovu · Weill Medical Coll Of Cornell Univ · U01 · FY2023 · DA

The Genome Analysis Core

$2,530,888
Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIC · FY2022 · AI

Monoclonal Antibody-based Multipurpose Microbicides

$2,530,562
Deborah J Anderson · Boston University Medical Campus · U19 · FY2014 · AI

HSV-1 Amplicon Vectors for HIV Vaccine Delivery

$2,530,347
University Of Rochester · P01 · FY2005 · AI

Clinical Epidemiology and Pathogenesis of Asymptomatic HSV

$2,529,656
Anna Wald · University Of Washington · P01 · FY2015 · AI

Next Generation HSC Gene Therapy for HIV Control and Eradication

$2,529,095
Paula M Cannon · University Of Southern California · U19 · FY2019 · HL

Next Generation HSC Gene Therapy for HIV Control and Eradication

$2,529,095
Paula M Cannon · University Of Southern California · U19 · FY2018 · HL

Development of Improved DNA Vaccines and Electroporation Delivery Devices for HIV

$2,529,017
Niranjan Sardesai · Viral Genomix, Inc. · N01 · FY2012 · AI

CASCADE: A North Carolina cohort to address the cascading effects of the HIV and substance use syndemic

$2,528,513
Christina S Meade · Wake Forest University Health Sciences · U01 · FY2025 · DA

HIV VACCINE DESIGN AND DEVELOPMENT TEAMS

$2,527,964
Advanced Biosciences Laboratories, Inc. · N01 · FY2000 · AI